Guy Serre

USPTO Granted Patents = 12 (Patent Applications = 3)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 33(Granted Patents)

Company Filing History:

Centre National De La Recherche Scientifique

patents

3 out of 124

Université Paul Sabatier (toulouse Iii)

Universite Paul Sabatier

patents

6. 1 out of 80

Pierre Fabre Dermo-cosmetique

patents

7. 1 out of 113

Chanel Parfums Beaute

patents

where one patent can have more than one assignee

Years Active: 1999-2022

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11479580 - Polypeptide expressed in the stratum corneum and use thereof (2022-10-25),

2. 9617307 - Polypeptide expressed in the stratum corneum and use thereof (2017-04-11),

3. 9566222 - Peptidyl arginine deiminase 1 and/or 3 activator compounds in the epidermis and uses thereof (2017-02-14),

4. 9388226 - Peptides modulating the activity of macrophages, useable for the treatment of rheumatoid arthritis (2016-07-12),

5. 9249208 - Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof (2016-02-02),

6. 9085635 - Polypeptide expressed in the stratum corneum and thereof (2015-07-21),

7. 8241856 - Method for detecting rheumatoid arthritis-specific autoantibodies (2012-08-14),

8. 8207299 - Citrulline peptides derived from fibrin and recognized by rheumatoid arthritis specific autoantibodies, and the use thereof (2012-06-26),

9. 7445903 - Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis (2008-11-04),

10. 7022485 - Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis (2006-04-04),

11. 6890720 - Antigens derived from filaggrin and their use for diagnosing rheumatoid polyarthritis (2005-05-10),

12. 5888833 - Antigens recognized by antibodies to rheumatoid arthritis, their (1999-03-30),

Title: The Innovations of Guy Serre

Introduction

Guy Serre is a notable inventor based in Toulouse, France. He has made significant contributions to the field of dermatological science, holding a total of 12 patents. His work primarily focuses on polypeptides and their applications in cosmetic and pharmaceutical compositions.

Latest Patents

Among his latest patents is a groundbreaking invention related to polypeptides expressed in the stratum corneum. This patent describes polypeptides belonging to the family of late proteins of the cornified envelope (LCE), along with fragments of the polypeptide and isolated nucleotide sequences encoding these polypeptides. The polypeptides have been shown to have cosmetic and therapeutic uses, particularly in reinforcing the barrier function of the epidermis. They are designed to prevent and treat signs of skin dryness and address disorders related to the barrier function or weakening of the epidermis.

Career Highlights

Throughout his career, Guy Serre has worked with prominent organizations such as bioMérieux, Inc. and the Centre National de la Recherche Scientifique. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of skin health.

Collaborations

Guy Serre has collaborated with esteemed colleagues, including Mireille Sebbag and Christian Vincent. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Guy Serre's contributions to the field of dermatology through his innovative patents highlight his expertise and dedication to improving skin health. His work continues to influence the cosmetic and pharmaceutical industries, showcasing the importance of scientific research in developing effective solutions for skin-related issues.

This text is generated by artificial intelligence and may not be accurate.